On closer inspection, the poor performance of these algorithms was discovered to be a result of the immense diversity in both CD34 biomarker staining patterns as well as features of the cells in the large image set, all part of the inescapable heterogeneity of patient tumor samples. Here, CD34 is linked to neoplasm.